Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

345 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interim PET-guided ABVD or ABVD/escalated BEACOPP for newly diagnosed advanced-stage classic Hodgkin lymphoma (JCOG1305).
Kusumoto S, Munakata W, Machida R, Terauchi T, Onaya H, Oguchi M, Iida S, Nosaka K, Suzuki Y, Harada Y, Miyazaki K, Maruta M, Fukuhara N, Toubai T, Kubota N, Ohmachi K, Saito T, Rai S, Mizuno I, Fukuhara S, Takeuchi M, Tateishi U, Maruyama D, Tsukasaki K, Nagai H. Kusumoto S, et al. Among authors: tateishi u. Cancer Sci. 2024 Oct;115(10):3384-3393. doi: 10.1111/cas.16281. Epub 2024 Jul 22. Cancer Sci. 2024. PMID: 39034771 Free PMC article.
End-of-treatment 18[F]-FDG PET can predict early progression in patients receiving bendamustine-rituximab for follicular lymphoma in first relapse: a prospective West Japan hematology Study Group (W-JHS) NHL01 trial.
Kato K, Izutsu K, Nishikori M, Shibayama H, Maeda Y, Yoshimura K, Tateishi U, Miyamoto T, Matsuda Y, Ishikawa J, Rai S, Takahashi T, Yamauchi T, Matsumura I, Akashi K, Kanakura Y, Suzumiya J. Kato K, et al. Among authors: tateishi u. Int J Hematol. 2024 Jun;119(6):677-685. doi: 10.1007/s12185-024-03738-8. Epub 2024 Mar 22. Int J Hematol. 2024. PMID: 38519820 Clinical Trial.
The Evolution and Clinical Impact of Deep Learning Technologies in Breast MRI.
Fujioka T, Fujita S, Ueda D, Ito R, Kawamura M, Fushimi Y, Tsuboyama T, Yanagawa M, Yamada A, Tatsugami F, Kamagata K, Nozaki T, Matsui Y, Fujima N, Hirata K, Nakaura T, Tateishi U, Naganawa S. Fujioka T, et al. Among authors: tateishi u. Magn Reson Med Sci. 2024 Oct 29. doi: 10.2463/mrms.rev.2024-0056. Online ahead of print. Magn Reson Med Sci. 2024. PMID: 39477506 Free article.
Prospective evaluation of PI-RADSv2.1 using multiparametric and biparametric MRI for detecting clinically significant prostate cancer based on MRI/US fusion-guided biopsy.
Yamaya N, Kimura K, Ichikawa R, Kawanishi M, Kawasaki Y, Higuchi S, Fukui K, Tsuchiya J, Kobayashi M, Yoshida S, Fujii Y, Tateishi U. Yamaya N, et al. Among authors: tateishi u. Jpn J Radiol. 2024 Oct 16. doi: 10.1007/s11604-024-01675-4. Online ahead of print. Jpn J Radiol. 2024. PMID: 39412644
AI Use in Mammography for Diagnosing Metachronous Contralateral Breast Cancer.
Adachi M, Fujioka T, Ishiba T, Nara M, Maruya S, Hayashi K, Kumaki Y, Yamaga E, Katsuta L, Hao D, Hartman M, Mengling F, Oda G, Kubota K, Tateishi U. Adachi M, et al. Among authors: tateishi u. J Imaging. 2024 Aug 28;10(9):211. doi: 10.3390/jimaging10090211. J Imaging. 2024. PMID: 39330431 Free PMC article.
345 results